Scope, Modalities, Format and Organization of the High-Level Plenary Meeting on Antimicrobial Resistance Convened by the President of the General Assembly

Requests the President of the General Assembly, with the support of the World Health Organization, the Food and Agriculture Organization of the United Nations, the United Nations Environment Programme, the World Organisation for Animal Health and other relevant partners, to organize and preside over an interactive multi-stakeholder hearing, before the end of June 2024, with the active participation of regional organizations, non-governmental organizations in consultative status with the Economic and Social Council, invited civil society organizations, philanthropic foundations, academia, medical associations, the private sector including the agriculture and food industry, broader communities, ensuring the participation and voices of women, children, youth, Indigenous Peoples, and people of African descent, as well as appropriate senior-level representatives of Member States, observers of the General Assembly, parliamentarians, representatives of local governments, and relevant United Nations entities, as part of the preparatory process for the high-level meeting, and also requests the President to prepare a summary of the hearing prior to the high-level meeting;

Encourages all Member States and members of the United Nations specialized agencies to participate in the high-level meeting, including the multi-stakeholder panels, at the highest possible level, preferably at the level of Heads of State and Government, and invites all observers of the General Assembly to be represented at the highest possible level;

Invites the United Nations system, including funds, programmes and specialized agencies, including the World Health Organization, the Food and Agriculture Organization of the United Nations, the United Nations Environment Programme as well as the World Organisation for Animal Health, the Global Leaders Group on Antimicrobial Resistance, the Inter-Parliamentary Union, regional commissions and relevant envoys of the Secretary-General, to participate in the high-level meeting, as appropriate, and urges them to consider relevant initiatives, such as the 2021 Call to Action on Antimicrobial Resistance, in support of the preparatory process and the high-level meeting, particularly with regard to sharing evidence and good practices, challenges and lessons learned;

Invites non-governmental organizations with relevant expertise that are in consultative status with the Economic and Social Council to register with the Secretariat to attend the high-level meeting and participate in the interactive multi-stakeholder hearing and the multi-stakeholder panels;

Invites members of civil society, non-governmental organizations, the private sector, academia, including research institutes, development partners and other relevant initiatives to make a fundamental contribution to the process in terms of raising awareness of the importance of addressing antimicrobial resistance;

Requests the President of the General Assembly to draw up a list of representatives of other relevant non-governmental organizations, civil society organizations, academic institutions and the private sector who may participate in the high-level meeting, including its panel discussions, taking into account the principles of transparency and equitable geographical representation, with due regard for gender parity, to submit the proposed list to Member States for their consideration on a non-objection basis⁸ and to bring the list to the attention of the Assembly for a final decision by the Assembly on participation in the high-level meeting;

Encourages Member States and members of the United Nations specialized agencies to include in their delegations to the high-level meeting ministers from all relevant ministries, as appropriate, representatives such as parliamentarians, mayors and governors, representatives of civil society, including non-governmental organizations, Indigenous Peoples, people of African descent, community organizations and faith-based organizations, academic institutions and the private sector with expertise in antimicrobial resistance, philanthropic foundations, and networks representing people affected by antimicrobial resistance, with due regard to gender balance and geographical representation;